Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Lipoma
Interventions
DRUG

Prednisolone synthetic cortisone and Isoproterenol together

Approximately 0.2 to 0.4cc of isoproterenol-prednisolone solution (0.04 - 0.08 mg isoproterenol and 0.07 - 0.14 mg prednisolone) in one or more sites in the lipoma depending on its size, 5 days a week for 4 weeks.

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Lipothera

UNKNOWN

lead

Pennington Biomedical Research Center

OTHER